AARDEX still confirms its leading position in the B2B medication adherence market, closing steadily more new deals with Pharma Companies, Biotech’s, Excellence Centers and Universities, over 30 countries in 2018.

AARDEX still confirms its leading position in the B2B medication adherence market, closing steadily more new deals with Pharma Companies, Biotech’s, Excellence Centers and Universities, over 30 countries in 2018.
The ‘Don’t Miss a Moment’ campaign – another chapter in the story of medication adherence Years from now, in a future where healthcare is far more digitally embedded than it is today, the date of 27 March 2025 might well
They might not always be easily identifiable, but millions of people across the globe are living with the debilitating symptoms of depression. This common mental disorder is thought to affect around 5% of the world’s adult population, with the pandemic